Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RGNX | REGENXBIO Inc. | Director | $178K | May 31, 2024 | ||
OCUP | Ocuphire Pharma, Inc. | Director | $177K | Oct 22, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|